Edgewise Therapeutics Inc's decision to offer and sell shares of common stock worth up to $125 million may impact its stock price. However, the short-term impact is uncertain as the offering will occur from time to time, and the market's reaction will depend on various factors such as the company's financial performance, market conditions, and investor sentiment.